Replies to post #15638 on GTC Biotherapeutics (fka GTCB)

[vinmantoo]

I would like to see somebody at GTCB finally recognize that cutting costs is a way to preserve shareholder "wealth" in difficult times. If they could cut out $5 million from their costs, the money from LFB would last into the fall of 2009. That would be more than enough to last past administrative delays in the FDA approval date.